DSPE-RGD Lipid

<strong>DSPE-RGD Lipid</strong>_x000D_ <strong>Catalog number:</strong> B2018972_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1460 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> DSPE-RGD Lipid, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-(cysarginylglycylaspartate-maleimidomethyl)cyclohexane-carboxamide] (sodium salt), sodium (6S,12S,15R)-1-amino-6-ammonio-15-(((1-((4-((2-((((R)-2,3-bis(stearoyloxy)propoxy)oxidophosphoryl)oxy)ethyl)carbamoyl)cyclohexyl)methyl)-2,5-dioxopyrrolidin-3-yl)thio)methyl)-12-(carboxylatomethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Huang J, Zhang X, Wu Z, Wu Y, Wu X, Wang Y, Jiang H, Ma J, He Z. Preparation and Biocompatibility Evaluation of PEG-PLL/RGD-PEG-DSPE/Phospholipid/CaP Nanoparticles J Biomed Nanotechnol. 2018 Jan 1;14(1):98-113._x000D_ 2: Song S, Mao G, Du J, Zhu X. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy Drug Deliv. 2016 May;23(4):1404-8._x000D_ 3: Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model Biomed Pharmacother. 2017 May;89:297-304._x000D_ 4: Chen CW, Lu DW, Yeh MK, Shiau CY, Chiang CH. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells Int J Nanomedicine. 2011;6:2567-80._x000D_ 5: Zhang X, He Z, Xiang L, Li L, Zhang H, Lin F, Cao H. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer Drug Des Devel Ther. 2019 Apr 29;13:1357-1372._x000D_ 6: Harvie P, Dutzar B, Galbraith T, Cudmore S, O'Mahony D, Anklesaria P, Paul R. Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs J Liposome Res. 2003 Nov;13(3-4):231-47._x000D_ 7: Zhou X, Liu HY, Zhao H, Wang T. RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment Onco Targets Ther. 2018 Sep 3;11:5397-5405._x000D_ 8: Zhang H. Buried cyclo(Arg-Gly-Tyr(Me)-Lys-Glu) microbubbles 2008 Jun 2 [updated 2008 Jul 21]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013._x000D_ 9: Cressman S, Dobson I, Lee JB, Tam YY, Cullis PR. Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells Bioconjug Chem. 2009 Jul;20(7):1404-11._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/30926479">10: Peng JQ, Fumoto S, Suga T, Miyamoto H, Kuroda N, Kawakami S, Nishida K. Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles J Control Release. 2019 May 28;302:42-53. </a>_x000D_ _x000D_ <strong>Products Related to DSPE-RGD Lipid can be found at</strong> <a href="https://moleculardepot.com/product-category/Lipids/"> Lipids</a>